PolyPid Ltd. (PYPD)
6.53
-0.01
(-0.15%)
USD |
NASDAQ |
Nov 18, 16:00
6.79
+0.26
(+3.98%)
After-Hours: 20:00
PolyPid Shareholders Equity (Quarterly) : 3.901M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.901M |
| June 30, 2026 | 5.388M |
| March 31, 2026 | 8.78M |
| December 31, 2025 | 10.97M |
| September 30, 2025 | 15.36M |
| June 30, 2025 | 20.48M |
| March 31, 2025 | 0.086M |
| December 31, 2024 | 7.684M |
| September 30, 2024 | 2.158M |
| June 30, 2024 | 1.601M |
| March 31, 2024 | 7.145M |
| December 31, 2023 | -2.096M |
| September 30, 2023 | 3.538M |
| June 30, 2023 | 8.347M |
| Date | Value |
|---|---|
| March 31, 2023 | 11.41M |
| December 31, 2022 | 5.829M |
| September 30, 2022 | 11.50M |
| June 30, 2022 | 19.11M |
| March 31, 2022 | 28.84M |
| December 31, 2021 | 35.96M |
| September 30, 2021 | 48.12M |
| June 30, 2021 | 56.88M |
| March 31, 2021 | 66.15M |
| December 31, 2020 | 72.78M |
| September 30, 2020 | 79.23M |
| June 30, 2020 | 84.48M |
| March 31, 2020 | 13.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 7.979B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 31.79M |
| Purple Biotech Ltd. | 12.27M |
| Sol-Gel Technologies Ltd. | 42.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.12M |
| Total Liabilities (Quarterly) | 36.22M |
| Debt to Equity Ratio | 0.3222 |
| Current Ratio | 5.940 |
| Net Debt Paydown Yield | 1.33% |